CYCCP - Cyclacel Pharmaceuticals Inc. (CYCC) CEO Spiro Rombotis on Q3 2021 Results - Earnings Call Transcript
Cyclacel Pharmaceuticals, Inc. (CYCC) Q3 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Spiro Rombotis - President and Chief Executive Officer Paul McBarron - Executive Vice President, Finance and Chief Operating Officer Mark Kirschbaum - Senior Vice President and Chief Medical Officer Conference Call Participants Jonathan Aschoff - ROTH Capital Kumar Raja - Brookline Capital Suzanne Rismiller - Oppenheimer Presentation Operator Good afternoon and welcome to the Cyclacel Pharmaceuticals’ Third Quarter 2021 Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. After today’s call, members of the financial community will have an opportunity to ask questions. [Operator Instructions] The company will also be accepting a limited number of questions submitted via email to the address, ir@cyclacel.com. [Operator Instructions] Please note, today’s call is being recorded. I would now like to turn the conference call over to the Company. Unidentified Company
For further details see:
Cyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q3 2021 Results - Earnings Call Transcript